Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology
Clinical guidelines: GLP-1 receptor agonists for weight management
Lancet Diabetes Endocrinol 8(5):392406 Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbll T, Warren ML, Bain SC (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
Ozempic (Semaglutide): Ideal for Type 2 Diabetes with Weight Benefits Though primarily approved for the treatment of Type 2 diabetes, Ozempic has also shown substantial weight reduction benefits in off-label use
On the same measure, cumulative revenues across the major pharmaceutical companies alone are projected to reach close to $165 billion by 2030 (Figure 1)
Shows activity in nervous system function and cognitive pathways in preclinical models [16]